Delivery Order V797D70110-36C24920N0056

Immucor Inc. has been awarded a $59,188.35 delivery order against its Federal Supply Schedule contract for blood bank reagents. The contract calls for Immucor to provide blood typing, compatibility testing, antibody screening, and other critical reagents to support the blood banking operations of the Defense Health Agency. Performance will take place in Norcross, Georgia through September 30, 2023. As the prime contractor for this delivery order, Immucor will leverage its expertise in...

This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...

This FY20 federal contract award from the Defense Health Agency is for $57,011.66 in blood bank reagents to be delivered by September 30, 2024. The prime contractor is Immucor Inc., a for-profit manufacturer of goods located in Norcross, Georgia. The contract was awarded on October 1, 2019 as a delivery order against the vendor's existing Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. No set-aside designation was used for this award. The reagents will support...

Immucor Inc. has been awarded a $122,190.27 firm fixed price delivery order by the Department of the Air Force Air Education and Training Command to provide FSC 6550 in vitro diagnostic reagents. The contract has no set-aside designation and requires performance through September 30, 2023 at Keesler Air Force Base in Mississippi. As a leading provider of blood banking products and services, Immucor supports critical transfusion medicine operations through multiple award schedule contracts and...

This is a firm fixed-price delivery order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical equipment, reagents, and supplies. The $59,572.95 contract is for blood bank reagents and is issued under Immucor's General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. This is not a set-aside contract. The contract has an ultimate completion date of October 1, 2028. Immucor holds several...

This is a federal contract awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs to Immucor Inc., a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The contract, valued at $39,019.95, is for the delivery of BLOOD BANK LAB REAGENTS. Immucor has previously held federal contracts to provide a variety of goods and services related to in vitro diagnostics, reagents,...

The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Immucor Inc., a for-profit manufacturer of goods, for the supply of reagents and the use of the Echo Lumena analyzer for blood bank operations. The base period of performance is from October 1, 2019, to September 30, 2020, with a potential total value of $905,144.61. The contract was awarded without a set-aside designation and is set to continue through September 30, 2022. Immucor is a leading...

This is a federal contract awarded by the U.S. Department of Veterans Affairs (VA) to Immucor Inc., a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. The $293,034.45 Delivery Order contract is for the supply of BLOOD BANK REAGENTS and is issued under Immucor's GSA Schedule 65-VII Indefinite Delivery Vehicle (IDV) for In Vitro Diagnostics, Reagents, and Test Kits. The contract has an ultimate completion date...

Immucor Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency on October 18, 2023. The contract has a potential value of $18,287.55 and requires delivery of Rapid Screen, Complement Control Cells, Panocell 20, and Immucor reagents by October 17, 2024 at Fort Belvoir, Virginia. No set-aside designation was used for this award to support the Defense Health Agency's medical products procurement programs. Immucor Inc. will serve as the...

Immucor Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency (DHA) to provide rapid screen, complement control cells, Panocell, and Immucor reagents. The contract has a potential value of $20,000 and requires delivery to Fort Belvoir, Virginia by November 9, 2021. No set-aside designation was used for this award made under an existing BPA. The reagents will support DHA's medical laboratory testing programs. Immucor will serve as the...